{"success":true,"data":{"pressRelease":{"id":"170319","rtpr_id":"nGNX7WQY9j-20261015","ticker":"SNES","exchange":"NASDAQ","all_tickers":["SNES"],"title":"SenesTech Reports Record Preliminary Third Quarter Revenue Exceeding $1 Million, the Highest in Company History, with 40% Sequential Growth","author":"Globe Newswire","published_at":"2026-10-15T12:30:00.477Z","article_body":"SURPRISE, Ariz., Oct. 15, 2026 (GLOBE NEWSWIRE) -- SenesTech, Inc. (NASDAQ:\nSNES\n(https://www.globenewswire.com/Tracker?data=-4lJI4vPdf75J4uPk0e1rPu93K7MuaAfWIPi8vcQlv6aC7sSylD966NyqVwg_a6xYKMk4GGStP4k-nSkqdGq3f_91PGQiH5K9dr0rdgWHCbW2qQbthzCca0QVvk0ekId)),\nthe leader in rodent birth control and sustainable rodent population\nmanagement, today announced preliminary revenue results for the third quarter\nof 2026. The Company plans to release its definitive third quarter financial\nresults the week of November 9, 2026.\n\nPreliminary third quarter 2026 revenue was approximately $1.1 million,\nrepresenting approximately 40% growth compared with the second quarter of 2026\nand approximately 55% growth compared with the third quarter of 2025. It was\nalso the Company’s first quarter at or above the $1 million revenue\nthreshold, a key milestone.\n\n\n\nThe Company expects its definitive third quarter financial results to reflect\ncontinued momentum in e-commerce, including higher subscription revenue, which\nis expanding the recurring component of SenesTech’s revenue base, as well as\nincreasing traction in B2B.\n\n“Our preliminary third quarter revenue marks an important milestone for\nSenesTech\n(https://www.globenewswire.com/Tracker?data=Cy32KVw4tPDN5noYwb-_lTFMrfLfTTy5mqyvoYMuVSHHf8Sql-GwXL1AA2c6w6Lf_KT95NYhHt2__fZNFa98Ulmyml1mLfmELQP2KwLT_-0=),\nreaching the $1 million threshold for the first time and setting a second\nconsecutive quarterly record,” said Michael Edell, Chief Executive Officer\nof SenesTech. “This is another quarter demonstrating progress on the plans\nand strategies we have previously announced, and our full third quarter\nfinancial results are expected to reflect that progress across the commercial\nmodel we have been building. E-commerce continues to scale as a controllable,\ndata-driven acquisition engine, our vertical-focused B2B organization is\ngaining traction, and higher subscription revenue is expanding our recurring\nrevenue base and improving the quality and visibility of revenue.”\n\n“We still have work to do, but we believe this is a clear indication that we\nare on the right path. We continue to lay the foundation for a much larger\ncompany in the future by working to expand e-commerce and B2B significantly in\na cost-effective manner. With many of the investments and transition costs\nincurred earlier in the year increasingly behind us, coupled with strong\nrevenue growth and improved unit economics, we expect continued, improved\nmetrics going forward,” Edell concluded.\n\nThe preliminary third quarter 2026 revenue presented in this release is\nunaudited, preliminary and subject to adjustment, and remains subject to\ncompletion of the Company’s quarter-end closing procedures.\n\nAbout SenesTech\n\nSenesTech is the leader in rodent birth control and sustainable rodent\npopulation management, with a mission to support a healthier environment\nthrough the responsible management of animal pest populations. The Company's\nEvolve® and ContraPest® fertility control solutions, along with its\nassessment and monitoring services, target reproduction to help reduce rodent\npopulations. SenesTech serves consumer and professional markets with proven\napproaches that can be used independently or as part of an integrated pest\nmanagement (IPM) program.\n\nFor more information, visit https://senestech.com.\n\nForward-Looking Statements\n\nThis press release contains “forward-looking statements” within the\nmeaning of Section 27A of the Securities Act of 1933, as amended, and Section\n21E of the Securities Exchange Act of 1934, as amended, which are intended to\nbe covered by the safe harbor provisions of the Private Securities Litigation\nReform Act of 1995. These include statements regarding the Company’s\nexpected third quarter 2026 revenue, anticipated momentum in e-commerce and\nincreasing traction in B2B, expected progress across the Company’s\ncommercial model, and anticipated continued, improved metrics going forward.\nWords such as “anticipate,” “believe,” “estimate,” “expect,”\n“intend,” “may,” “plan,” “project,” “should,” “will”\nand similar expressions are intended to identify forward-looking statements,\nalthough not all forward-looking statements contain these words.\nForward-looking statements are based on current expectations and assumptions\nand are subject to risks and uncertainties that could cause actual results to\ndiffer materially from those expressed or implied. These risks include the\nrisk that the Company may not realize the benefits expected from its\ne-commerce, B2B and subscription strategies, or be successful in\ncommercialization of its products, realize sufficient market acceptance of its\nproducts, or capitalize on market opportunities and accelerate growth; the\nrisks of establishing an entirely new product category, including the time,\nexpense and uncertainty of building market awareness and customer acceptance;\nthe risk that the Company may not be able to build and scale a professional\nB2B sales organization and to execute a vertical-market strategy; risks\nrelated to the Company’s financial performance, including its ability to\nfund operations and potentially using cash at times and in ways other than as\nplanned; and risks related to regulatory approval and regulation of the\nCompany’s products. These and other risks are described more fully in the\nCompany’s filings with the Securities and Exchange Commission, including\nunder “Risk Factors” in its Annual Report on Form 10-K for the fiscal year\nended Dec. 31, 2025, and subsequent Quarterly Reports on Form 10-Q. Readers\nare cautioned not to place undue reliance on these forward-looking statements,\nwhich speak only as of the date of this release. Except as required by law,\nSenesTech undertakes no obligation to update or revise any forward-looking\nstatement.\n\nContacts:\n\nInvestor: Robert Blum, Lytham Partners, LLC, 602-889-9700,\nsenestech@lythampartners.com\nCompany: Tom Chesterman, Chief Financial Officer, SenesTech, Inc.,\n928-779-4143\n\nA photo accompanying this announcement is available at\nhttps://www.globenewswire.com/NewsRoom/AttachmentNg/f7d86ed3-87e0-435b-8b6f-e2a140aec821\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/1bffadd8-22e1-44ee-b7ca-c8115e24e3fd)\nSenesTech: NASDAQ: SNES \n(https://www.globenewswire.com/NewsRoom/AttachmentNg/f7d86ed3-87e0-435b-8b6f-e2a140aec821/en)\nSenesTech: NASDAQ: SNES\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNX7WQY9j-20261015","title":"SenesTech Reports Record Preliminary Third Quarter Revenue Exceeding $1 Million, the Highest in Company History, with 40% Sequential Growth","author":"Globe Newswire","ticker":"SNES","created":"2026-10-15T12:30:00.477Z","tickers":["SNES"],"exchange":"NASDAQ","article_body":"SURPRISE, Ariz., Oct. 15, 2026 (GLOBE NEWSWIRE) -- SenesTech, Inc. (NASDAQ:\nSNES\n(https://www.globenewswire.com/Tracker?data=-4lJI4vPdf75J4uPk0e1rPu93K7MuaAfWIPi8vcQlv6aC7sSylD966NyqVwg_a6xYKMk4GGStP4k-nSkqdGq3f_91PGQiH5K9dr0rdgWHCbW2qQbthzCca0QVvk0ekId)),\nthe leader in rodent birth control and sustainable rodent population\nmanagement, today announced preliminary revenue results for the third quarter\nof 2026. The Company plans to release its definitive third quarter financial\nresults the week of November 9, 2026.\n\nPreliminary third quarter 2026 revenue was approximately $1.1 million,\nrepresenting approximately 40% growth compared with the second quarter of 2026\nand approximately 55% growth compared with the third quarter of 2025. It was\nalso the Company’s first quarter at or above the $1 million revenue\nthreshold, a key milestone.\n\n\n\nThe Company expects its definitive third quarter financial results to reflect\ncontinued momentum in e-commerce, including higher subscription revenue, which\nis expanding the recurring component of SenesTech’s revenue base, as well as\nincreasing traction in B2B.\n\n“Our preliminary third quarter revenue marks an important milestone for\nSenesTech\n(https://www.globenewswire.com/Tracker?data=Cy32KVw4tPDN5noYwb-_lTFMrfLfTTy5mqyvoYMuVSHHf8Sql-GwXL1AA2c6w6Lf_KT95NYhHt2__fZNFa98Ulmyml1mLfmELQP2KwLT_-0=),\nreaching the $1 million threshold for the first time and setting a second\nconsecutive quarterly record,” said Michael Edell, Chief Executive Officer\nof SenesTech. “This is another quarter demonstrating progress on the plans\nand strategies we have previously announced, and our full third quarter\nfinancial results are expected to reflect that progress across the commercial\nmodel we have been building. E-commerce continues to scale as a controllable,\ndata-driven acquisition engine, our vertical-focused B2B organization is\ngaining traction, and higher subscription revenue is expanding our recurring\nrevenue base and improving the quality and visibility of revenue.”\n\n“We still have work to do, but we believe this is a clear indication that we\nare on the right path. We continue to lay the foundation for a much larger\ncompany in the future by working to expand e-commerce and B2B significantly in\na cost-effective manner. With many of the investments and transition costs\nincurred earlier in the year increasingly behind us, coupled with strong\nrevenue growth and improved unit economics, we expect continued, improved\nmetrics going forward,” Edell concluded.\n\nThe preliminary third quarter 2026 revenue presented in this release is\nunaudited, preliminary and subject to adjustment, and remains subject to\ncompletion of the Company’s quarter-end closing procedures.\n\nAbout SenesTech\n\nSenesTech is the leader in rodent birth control and sustainable rodent\npopulation management, with a mission to support a healthier environment\nthrough the responsible management of animal pest populations. The Company's\nEvolve® and ContraPest® fertility control solutions, along with its\nassessment and monitoring services, target reproduction to help reduce rodent\npopulations. SenesTech serves consumer and professional markets with proven\napproaches that can be used independently or as part of an integrated pest\nmanagement (IPM) program.\n\nFor more information, visit https://senestech.com.\n\nForward-Looking Statements\n\nThis press release contains “forward-looking statements” within the\nmeaning of Section 27A of the Securities Act of 1933, as amended, and Section\n21E of the Securities Exchange Act of 1934, as amended, which are intended to\nbe covered by the safe harbor provisions of the Private Securities Litigation\nReform Act of 1995. These include statements regarding the Company’s\nexpected third quarter 2026 revenue, anticipated momentum in e-commerce and\nincreasing traction in B2B, expected progress across the Company’s\ncommercial model, and anticipated continued, improved metrics going forward.\nWords such as “anticipate,” “believe,” “estimate,” “expect,”\n“intend,” “may,” “plan,” “project,” “should,” “will”\nand similar expressions are intended to identify forward-looking statements,\nalthough not all forward-looking statements contain these words.\nForward-looking statements are based on current expectations and assumptions\nand are subject to risks and uncertainties that could cause actual results to\ndiffer materially from those expressed or implied. These risks include the\nrisk that the Company may not realize the benefits expected from its\ne-commerce, B2B and subscription strategies, or be successful in\ncommercialization of its products, realize sufficient market acceptance of its\nproducts, or capitalize on market opportunities and accelerate growth; the\nrisks of establishing an entirely new product category, including the time,\nexpense and uncertainty of building market awareness and customer acceptance;\nthe risk that the Company may not be able to build and scale a professional\nB2B sales organization and to execute a vertical-market strategy; risks\nrelated to the Company’s financial performance, including its ability to\nfund operations and potentially using cash at times and in ways other than as\nplanned; and risks related to regulatory approval and regulation of the\nCompany’s products. These and other risks are described more fully in the\nCompany’s filings with the Securities and Exchange Commission, including\nunder “Risk Factors” in its Annual Report on Form 10-K for the fiscal year\nended Dec. 31, 2025, and subsequent Quarterly Reports on Form 10-Q. Readers\nare cautioned not to place undue reliance on these forward-looking statements,\nwhich speak only as of the date of this release. Except as required by law,\nSenesTech undertakes no obligation to update or revise any forward-looking\nstatement.\n\nContacts:\n\nInvestor: Robert Blum, Lytham Partners, LLC, 602-889-9700,\nsenestech@lythampartners.com\nCompany: Tom Chesterman, Chief Financial Officer, SenesTech, Inc.,\n928-779-4143\n\nA photo accompanying this announcement is available at\nhttps://www.globenewswire.com/NewsRoom/AttachmentNg/f7d86ed3-87e0-435b-8b6f-e2a140aec821\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/1bffadd8-22e1-44ee-b7ca-c8115e24e3fd)\nSenesTech: NASDAQ: SNES \n(https://www.globenewswire.com/NewsRoom/AttachmentNg/f7d86ed3-87e0-435b-8b6f-e2a140aec821/en)\nSenesTech: NASDAQ: SNES\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-10-15T12:30:00.946782292Z","server_sent_at_ms":1792067400946},"received_at":"2026-10-15T12:30:00.997Z","source_url":null},"analysis":{"id":"158512","press_release_id":"170319","analysis_json":{"industry":{"label":"Chemicals","sector":"Materials"},"redFlags":["figures are preliminary and unaudited, subject to quarter-end closing procedures","micro-cap with only ~$1.1M quarterly revenue; profitability not addressed"],"eventType":"earnings","narrative":"SenesTech reported preliminary Q3 2026 revenue of approximately $1.1 million, up roughly 40% sequentially and 55% year-over-year, its first quarter at or above the $1 million threshold.\n\nThe company expects definitive results, due the week of November 9, to show continued e-commerce momentum with growing subscription revenue and increasing B2B traction.\n\nCEO Michael Edell said earlier-year investments and transition costs are increasingly behind the company, and management expects improved metrics going forward; the preliminary figures are unaudited and subject to adjustment.","sentiment":"bullish","agentHooks":{"shouldPost":true,"suggestedAngle":"Micro-cap SenesTech crosses $1M quarterly revenue for the first time with accelerating e-commerce and subscription growth ahead of full Q3 results."},"keyFigures":{"revenue":1100000,"revenueYoy":"55%","customDimensions":{"milestone":"first quarter at or above $1 million revenue","sequential_growth":"40%"}},"quotedText":"This is another quarter demonstrating progress on the plans and strategies we have previously announced, and our full third quarter financial results are expected to reflect that progress across the commercial model we have been building.","namedEntities":{"people":[{"name":"Michael Edell","role":"CEO"},{"name":"Tom Chesterman","role":"CFO"},{"name":"Robert Blum","role":"Investor relations contact, Lytham Partners"}],"products":["Evolve","ContraPest"],"companies":[{"name":"SenesTech, Inc.","ticker":"SNES","relationship":"filer"},{"name":"Lytham Partners, LLC","relationship":"investor relations firm"}],"dollarAmounts":[{"amount":"$1.1 million","context":"preliminary Q3 2026 revenue"},{"amount":"$1 million","context":"quarterly revenue milestone threshold"}]},"materialImpact":{"score":3,"reasoning":"Preliminary Q3 revenue pre-announcement with record ~$1.1M revenue, +40% sequential and +55% YoY, crossing the $1M quarterly milestone for the first time. Positive for a micro-cap, but the absolute figures are small and results are unaudited; definitive results come the week of November 9."},"tickerRelevance":{"others":[],"primary":"SNES"},"globalImportance":25,"audienceRelevance":20,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"micro-cap","eventGravity":"preliminary revenue pre-announcement, record but small absolute figures","issuerAuthored":true,"retailFavoriteBoost":"small — niche rodent-control products"}},"event_type":"earnings","event_type_secondary":null,"sentiment":"bullish","material_impact_score":3,"narrative":"SenesTech reported preliminary Q3 2026 revenue of approximately $1.1 million, up roughly 40% sequentially and 55% year-over-year, its first quarter at or above the $1 million threshold.\n\nThe company expects definitive results, due the week of November 9, to show continued e-commerce momentum with growing subscription revenue and increasing B2B traction.\n\nCEO Michael Edell said earlier-year investments and transition costs are increasingly behind the company, and management expects improved metrics going forward; the preliminary figures are unaudited and subject to adjustment.","key_figures":{"revenue":1100000,"revenueYoy":"55%","customDimensions":{"milestone":"first quarter at or above $1 million revenue","sequential_growth":"40%"}},"named_entities":{"people":[{"name":"Michael Edell","role":"CEO"},{"name":"Tom Chesterman","role":"CFO"},{"name":"Robert Blum","role":"Investor relations contact, Lytham Partners"}],"products":["Evolve","ContraPest"],"companies":[{"name":"SenesTech, Inc.","ticker":"SNES","relationship":"filer"},{"name":"Lytham Partners, LLC","relationship":"investor relations firm"}],"dollarAmounts":[{"amount":"$1.1 million","context":"preliminary Q3 2026 revenue"},{"amount":"$1 million","context":"quarterly revenue milestone threshold"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-15T12:30:10.523Z","global_importance":25,"audience_relevance":20,"importance_components":{"tickerTier":"micro-cap","eventGravity":"preliminary revenue pre-announcement, record but small absolute figures","issuerAuthored":true,"retailFavoriteBoost":"small — niche rodent-control products"}},"durationMs":5939,"modelName":"glm-5.3-flashx"}}